Why did Pfizer acquire Array BioPharma?

Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need.

Will array common stock be traded on the NASDAQ Global Market?

Array common stock will cease to be traded on the Nasdaq Global Market. Pfizer expects the transaction to be dilutive to Pfizer’s Adjusted Diluted EPS by $0.04 in 2019, $0.04 -$0.05 in 2020, neutral in 2021 and accretive beginning in 2022, with additional accretion and growth anticipated thereafter.

Where is Array BioPharma Inc headquartered?

The company was founded in 1998 and is headquartered in Boulder, Colorado. View today's Array BioPharma Inc stock price and latest ARRY_old news and analysis. Create real-time notifications to follow any changes in the live stock price.